Publications
2 November 2026
Discover tRIBO-seq, a nanopore-based method to profile actively translating tRNAs and reveal changes in their abundance, modifications and fragmentation under stress.
Events
30 October 2026
Join Immagina Biotechnology in November 2026 at RNA conferences, PEGS Europe, and scientific meetings across the US and Europe. Meet our team to explore RNA research, translatomics, and new opportunities for collaboration.
Publications
28 October 2026
Researchers identify AARS1 as a potential target in ovarian cancer. Using Ribo-seq and multi-omics approaches, the study shows how AARS1 regulates IRF7 translation and type I interferon signaling, revealing a way to improve antitumor immunity.
Publications
19 October 2026
A study published in Nature Cell Biology reveals how ADAR1 and FTSJ1 regulate mistranslation in cancer cells under tryptophan-limiting conditions. IMMAGINA Biotechnology contributed nano-tRNA sequencing expertise to investigate the role of tRNA modificati
Blog
15 October 2026
Having more mRNA does not always mean producing more protein. Understanding how efficiently an mRNA is translated can help researchers improve therapeutic design. Explore the factors influencing translation efficiency and how ribosome profiling provides i
Webinar & podcast
13 October 2026
How can complementary RNA technologies help researchers address complex questions in cancer biology? Watch our European RNA Alliance (ERA) webinar to explore how integrated approaches to RNA analysis, functional genomics, and translatomics can provide dee